Adma Biologics (ADMA) Gross Profit Growth (5y) (2016 - 2025)
Adma Biologics (ADMA) Gross Profit Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - |
| 2 | Nanobiotix | 1,910.87 Bn | 1,910.81 Bn | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.14 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.46 Bn | 37.46 Bn | - |
| 10 | Adma Biologics | 2.04 Bn | 1.95 Bn | 88.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 80.63% |
| Sep 30, 2025 | 52.87% |
| Jun 30, 2025 | 57.62% |
| Mar 31, 2025 | 62.17% |
| Dec 31, 2024 | 34.82% |
| Sep 30, 2024 | 54.55% |
| Jun 30, 2024 | 79.16% |
| Mar 31, 2024 | 53.98% |
| Dec 31, 2023 | 76.87% |
| Sep 30, 2023 | 61.31% |
| Jun 30, 2023 | 42.08% |
| Mar 31, 2023 | 50.03% |
| Dec 31, 2022 | 137.63% |
| Sep 30, 2022 | 25.43% |
| Jun 30, 2022 | 59.47% |
| Mar 31, 2022 | 30.25% |
| Dec 31, 2021 | 9.54% |
| Sep 30, 2021 | -23.34% |
| Jun 30, 2021 | -24.78% |
| Mar 31, 2021 | -32.00% |